Photokeratoconjunctivitis is a serious eye condition that affects millions of people worldwide. It is characterized by inflammation of the cornea and conjunctiva, and is often accompanied by the presence of light-sensitive cells in the eye. In severe cases, it can cause permanent vision loss. In this article, we will explore the causes and treatments of photokeratoconjunctivitis, so that doctors can better understand and diagnose this condition.
Photokeratoconjunctivitis, also known as PKC, is an inflammatory condition of the cornea and conjunctiva that is caused by exposure to ultraviolet (UV) light. It is most commonly caused by overexposure to sunlight, but can also be caused by exposure to artificial UV light sources, such as tanning beds. Symptoms of PKC include redness, swelling, and pain in the eyes. In severe cases, it can lead to vision loss.
The primary cause of photokeratoconjunctivitis is overexposure to UV light. This can be from either direct sunlight or artificial sources, such as tanning beds. People who work outdoors, such as farmers and construction workers, are particularly at risk for this condition. In addition, people who wear contact lenses are more susceptible to PKC, as the lenses can filter out some of the UV light.
Anyone who is exposed to excessive amounts of UV light is at risk for developing photokeratoconjunctivitis. This includes people who spend a lot of time outside, such as farmers and construction workers, as well as people who use tanning beds. Additionally, people who wear contact lenses are more susceptible to PKC, as the lenses can filter out some of the UV light.
If a doctor suspects that a patient has photokeratoconjunctivitis, they will typically begin by performing a physical exam of the eyes. They will look for signs of inflammation, such as redness and swelling, as well as any light-sensitive cells that may be present. The doctor may also order a corneal topography test to assess the shape and thickness of the cornea.
The primary goal of treatment for photokeratoconjunctivitis is to reduce inflammation and prevent vision loss. The doctor may prescribe topical corticosteroids to reduce the inflammation, as well as artificial tears to lubricate the eyes. In more severe cases, the doctor may recommend a corneal transplant to replace the damaged cornea.
The best way to prevent photokeratoconjunctivitis is to limit exposure to UV light. This can be done by wearing sunglasses or a wide-brimmed hat when outdoors, as well as avoiding tanning beds.
Photokeratoconjunctivitis is a serious eye condition that can lead to permanent vision loss. It is caused by overexposure to UV light, and is most commonly seen in people who work outdoors or use tanning beds. If a doctor suspects that a patient has this condition, they will typically begin by performing a physical exam of the eyes and may order a corneal topography test. Treatment for photokeratoconjunctivitis typically involves topical corticosteroids and artificial tears, and in more severe cases, a corneal transplant may be necessary.
1.
Remote monitoring can improve recovery from cancer surgery
2.
Intractable cancers may respond better to treatment when using new radiation and high-performance computing.
3.
A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials
4.
Conditional EU Nod for Weekly Pill in Pediatric Glioma
5.
high response rate when using a bispecific antibody to treat R/R multiple myeloma.
1.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
2.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
5.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation